Statistics

Total Visits

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro56

Select a period of time:

Number of views in the range

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro25

Views

Views
April 20252
May 20255
June 20255
July 20257
August 20251
September 20255
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore10
United States9
Brazil3
Colombia1
Spain1
United Kingdom1
 

Top cities views

Views
Dallas4
Calumet City1
Council Bluffs1
Curitiba1
Hicksville1
Itajaí1
Leander1
Santiago de Cali1
Sorocaba1